THE INTERNSHIP In this role you will join the Clinical Development & Operations team in our offices based in Milan. You will support operational and scientific set-up, execution, and delivery of the clinical trials at the
Do you enjoy working with cutting-edge technology? Would you like to help shape the future of our global energy? Join our Team! Baker Hughes IET GTS Upgrades team provides industry-leading products and services that optimize the
If you’ve worn a pair of glasses, we’ve already met. We are a global leader in the design, manufacture, and distribution of ophthalmic lenses, frames, and sunglasses. We offer our industry stakeholders in over 150 countries
Business Area: R&D, Pharmacovigilance & Regulatory Affairs Job Type: Direct Employee Contract Type: Permanent Location: Italy, IT Responsibilities End to end execution of assigned innovation and initiatives, translating strategies and study designs on time, quality, and
About us Chiesi is an international research-focused biopharmaceutical group with 90 years experience, operating in more than 30 countries, with its Headquarter in Parma, Italy. More than 8,000 employees across the group are united by a
About us Chiesi is an international research-focused biopharmaceutical group with 90 years’ experience, operating in more than 30 countries, with its Headquarter in Parma, Italy. More than 8,000 employees across the group are united by a
Descrizione dell’offerta di lavoro. Do you enjoy working with cutting-edge technology? Would you like to help shape the future of our global energy? Baker Hughes IET Industrial Commercial team provides industry-leading products and services that optimize
About ITT: ITT Inc. (NYSE: ITT) is a diversified global leading manufacturer of highly engineered critical components and customized technology solutions serving the flow, aerospace and defense, transportation, industrial, and energy markets. Through operational execution, innovation,
Our client is an international industrial group backed by global PE . In the last 6 years they have doubled up the top line up to 2Bn€ (2025), tripled their profitability, established their presence in 28